CVRx, Inc. Common Stock earnings per share and revenue
On Nov 05, 2025, CVRX reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.51 USD, resulting in a 4.20% surprise. Revenue reached 14.69 million, compared to an expected 14.44 million, with a 1.73% difference. The market reacted with a +2.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.44 USD, with revenue projected to reach 16.08 million USD, implying an decrease of -10.20% EPS, and increase of 9.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were CVRx, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CVRx, Inc. Common Stock reported EPS of -$0.49, beating estimates by 4.2%, and revenue of $14.69M, 1.73% above expectations.
How did the market react to CVRx, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.66%, changed from $9.79 before the earnings release to $10.05 the day after.
When is CVRx, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for CVRx, Inc. Common Stock's next earnings report?
Based on 9
analysts, CVRx, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of $16.08M for Q4 2025.